Occudo Quantitative Strategies’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$87.9K Sell
12,310
-4,326
-26% -$37.7K 0.01% 694
2026
Q2
$144K Buy
16,636
+1,536
+10% +$12.1K 0.01% 712
2026
Q1
$114K Buy
+15,100
New +$113K 0.01% 703
2024
Q1
– Sell
-4,767
Closed -$144K – 706
2023
Q4
$144K Sell
4,767
-304
-6% -$6.63K 0.02% 683
2023
Q3
$111K Sell
5,071
-3,900
-43% -$138K 0.01% 869
2023
Q2
$349K Buy
+8,971
New +$792K 0.04% 694

Other funds holding ACET

Occudo Quantitative Strategies's ACET Position: Q3 2026 in Review

Occudo Quantitative Strategies reduced its Adicet Bio (ACET) stake by 26% in Q3 2026, selling an estimated $37.7K and leaving 12,310 shares worth $87.9K. The position accounts for 0.01% of the portfolio, ranked #694.

Occudo Quantitative Strategies first reported a position in ACET in Q2 2023 and has held it in 6 quarters since. The position peaked at $349K in Q2 2023. 54 funds tracked by Wall St. Rank hold ACET as of Q3 2026.

  • Occudo Quantitative Strategies held 12,310 shares of Adicet Bio worth $87.9K as of Q3 2026.
  • Occudo Quantitative Strategies sold 4,326 Adicet Bio shares in Q3 2026, an estimated $37.7K.
  • Adicet Bio made up 0.01% of Occudo Quantitative Strategies's portfolio in Q3 2026, its #694 holding.
  • Occudo Quantitative Strategies first reported a position in Adicet Bio in Q2 2023 and has held it in 6 quarters since.
  • Occudo Quantitative Strategies's Adicet Bio position peaked at $349K in Q2 2023.
  • 54 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2026, filed 16 Nov 2026.